CD8A and neoplasm: The results showed that oHSV2 treatment reshaped the tumor immune microenvironment, with the reduction of inhibitory immune cells [regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs)] and increment of positive immune cells [CD8+ T, natural killer (NK), and dendritic cells (DCs)] [9].